Please login to the form below

Not currently logged in
Email:
Password:

Lilly/Lupin Indian diabetes partnership

Eli Lilly & Company has entered into a deal with India-based pharmaceutical firm Lupin to market Lilly's Huminsulin range of products for people with diabetes in India and Nepal

Eli Lilly & Company has entered into a deal with India-based pharmaceutical firm Lupin to market Lilly's Huminsulin range of products for people with diabetes in India and Nepal.

Lilly said the deal would double the current customer base for the products, with around 45,000 doctors to be targeted by Lupin. Financial details were not disclosed.

There are currently around 51 million people with diabetes in India, making the country an increasing priority for pharmaceutical companies whose portfolio includes diabetes products. It is estimated there will be 85 million living with the condition in India by 2030.

Eberhard Ludewigs, vice-president, Emerging Markets, Lilly, said: "As our highest priority, diabetes is a clear 'must win' for Lilly emerging markets. This partnership will allow us to change our game in India. We will have a stronger footprint with many more sales representatives promoting our diabetes brands, and this will become a foundation to expand our diabetes business not only for current products, but also for our future pipeline.”

Previous diabetes-related partnerships in India include Sun Pharma and MSD (known as Merck in the US and Canada). In April the companies agreed to co-market MSD's diabetes drugs, sitagliptin and sitagliptin plus metformin in the India.

1st August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics